Endocrine & Metabolic Disorders

ICON's endocrine and metabolic trial experience, supported by a global team of experts

A multifaceted risk factor:

Addressing obesity's impact across the disease spectrum

Obesity is a growing health concern worldwide, with at least 2.8 million people dying each year because of the disease. Explore the implications of obesity as a risk factor across the disease spectrum, and how this may impact treatment, drug development and clinical trials for obesity. 

Read the whitepaper

ICON survey report:

Trends and challenges in obesity research and clinical trials

Explore the ICON survey of global industry professionals currently engaged in obesity-related clinical research. Respondents were from organisations ranging from small biotechs to large pharmaceutical companies, as well as academic organisations. The survey was designed to measure industry opinions on trends and challenges for the sector. 

View the survey results

Webinar: Addressing the challenges of Type 2 Diabetes global clinical trials via high quality lab solutions

Join ICON’s expert Dr. Andrew Roche, PhD as he speaks about overcoming challenges when developing Diabetes trials. Addressing these challenges via use of high quality tools is critical to successful completion of a clinical trial.

Watch the webinar

Webinar: Digital solutions to alleviate NASH clinical trial challenges

Find out more about the ability for digital technologies including magnetic resonance imaging (MRI), magnetic resonance elastography (MRE) and whole slide imaging (WSI) to address NASH clinical trial challenges.

Watch the webinar

Endocrine and Metabolic Disorders blogs and media contributions

Endocrine & Metabolic Disorders services

ICON is an experienced partner who can assist sponsors in navigating the many challenges of endocrine & metabolic disorders drug development. ICON can help sponsors optimise the clinical trial lifecycle from patient enrolment to payer reimbursement with its customisable solutions and proven strategies. Our highly experienced clinical and therapeutic teams have expertise in conducting trials across a wide range of therapeutic areas including, diabetes, cardiometabolic disorders, gastroenterology, and hepatology.

Explore ICON's services in endocrine & metabolic disorders